Effects of Chronic Stress Stimulation on the Occurrence and Development of Tumors and the Regulatory Role of Chinese Medicine

Wenqin Guo; Rongzhen Shi

doi:10.62767/jecacm501.8668

Authors

Wenqin Guo College of Basic Medical Science, Zhejiang Chinese Medical University, 310053 Hangzhou, China Author
Rongzhen Shi Linping District Traditional Chinese Medicine Hospital Tangqi Branch, 310053 Hangzhou, China Author

DOI:

https://doi.org/10.62767/jecacm501.8668

Keywords:

chronic stress, tumor, regulation of traditional Chinese medicine, emotional disorders

Abstract

Chronic stress refers to the continuous non-specific adaptive response of the body caused by the activation of the classic hypothalamic-pituitary-adrenal axis neuroendocrine system and sympathetic nervous system, which not only affects sleep quality, appetite, and gastrointestinal function, but also increases the risk of atherosclerosis, cardiovascular disease, mental disorders, and tumors. Notably, chronic stress has been confirmed to induce tumorigenesis and promote tumor evolution, especially on the immune function of the body and the remodeling of the tumor microenvironment. Therefore, it is essential and important to improve the emotional disorders caused by chronic stress stimulation in cancer patients. Many studies have proved that traditional Chinese medicine and compound regulation can significantly improve anxiety, depression and tumor development in patients. In this article, the mechanism of CUMS affecting tumor and the therapeutic effect of traditional Chinese medicine compound are reviewed, so as to provide reference for the adjuvant treatment of cancer by traditional Chinese medicine.

References

Tian WT, Liu Y, Cao CH, et al. Corrigendum: Chronic Stress: Impacts on Tumor Microenvironment and Implications for Anti-Cancer Treatments. Frontiers in Cell and Developmental Biology 2022; 10: 865043.

Liu YX, Tian S, Ning B, et al. Stress and cancer: the mechanisms of immune dysregulation and management. Frontiers in Immunology 2022; 13: 1032294.

Kruk J, Aboul-Enein B, Bernstein J, et al. Psychological stress and cellular aging in cancer: a meta-analysis. Oxidative Medicine and Cellular Longevity 2019; 2019: 1270397.

Rao R, Androulakis I.P. Allostatic adaptation and personalized physiological trade-offs in the circadian regulation of the HPA axis: a mathematical modeling approach. Scientific Reports 2019; 9(1): 11212.

Karvonen H, Arjama M, Kaleva L, et al. Glucocorticoids induce differentiation and chemoresistance in ovarian cancer by promoting ROR1-mediated stemness. Cell Death & Disease 2020; 11(9): 790.

Amato R, D'Antona L, Porciatti G, et al. Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation. Journal of Molecular Medicine 2009; 87(12): 1221-1239.

Zubeldia-Plazaola A, Recalde-Percaz L, Moragas N, et al. Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis. Breast Cancer Research 2018; 20(1): 65.

Cui B, Luo YY, Tian PF, et al. Stress-induced epinephrine enhances lactate dehydrogenase A and promotes breast cancer stem-like cells. The Journal of Clinical Investigation 2019; 129(3): 1030-1046.

Zhi XF, Li BW, Li Z, et al. Adrenergic modulation of AMPK-dependent autophagy by chronic stress enhances cell proliferation and survival in gastric cancer. International Journal of Oncology 2019; 54(5): 1625-1638.

Liu JX, Qu LS, Wan CH, et al. A novel β2-AR/YB-1/β-catenin axis mediates chronic stress-associated metastasis in hepatocellular carcinoma. Oncogenesis 2020; 9(9): 84.

Nilsson MB, Le XN, Heymach JV. β-Adrenergic signaling in lung cancer: a potential role for beta-blockers. Journal of Neuroimmune Pharmacology 2020, 15(1): 27-36.

Krizanova O, Babula P, Pacak K. Stress, catecholaminergic system and cancer. Stress 2016; 19(4): 419-428.

Moreno-Smith M, Lu C, Shahzad MMK, et al. Dopamine Blocks Stress-mediated Ovarian Carcinoma Growth. Clinical Cancer Research 2021; 27(15): 4451.

Song C, Halbreich U, Han C, et al. Imbalance between pro- and anti-inflammatory cytokines, and between Th1 and Th2 cytokines in depressed patients: the effect of electroacupuncture or fluoxetine treatment. Pharmacopsychiatry 2009; 42(5): 182-188.

Colon-Echevarria CB, Lamboy-Caraballo R, Aquino-Acevedo AN, et al. Neuroendocrine regulation of tumor-associated immune cells. Frontiers in Oncology 2019; 9: 1077.

Sloan EK, Priceman SJ, Cox BF, et al. The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Research 2010; 70(18): 7042-7052.

Li MF, Wang YF, Lu L. The effect of chronic psychological stress on the Th1/Th2 cytokines in mice. Chinese Journal of Integrative Medicine on Cardio/Cerebrovascular Disease 2014; 12(7): 868-869.

Yu LX, Schwabe RF. The gut microbiome and liver cancer: Mechanisms and clinical translation. Nature Reviews Gastroenterology & Hepatology 2017; 14(9): 527-539.

Thiele Orberg E, Fan H, Tam AJ, et al. The myeloid immune signature of enterotoxigenic bacteroides fragilis-induced murine colon tumorigenesis. Mucosal Immunology 2017; 10(2): 421-433.

Ridlon JM, Wolf PG, Gaskins HR. Taurocholic acid metabolism by gut microbes and colon cancer. Gut Microbes 2016; 7(3): 201-215.

Silva YP, Bernardi A, Frozza RL. The role of short-chain fatty acids from gut microbiota in gut-brain communication. Frontiers in Endocrinology 2020; 11: 25.

Settanni CR, Ianiro G, Bibbò S, et al. Gut microbiota alteration and modulation in psychiatric disorders: Current evidence on fecal microbiota transplantation. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2021; 109: 110258.

Villarreal-García V, Estupiñan-Jiménez JR, Vivas-Mejía PE, et al. A vicious circle in breast cancer: The interplay between inflammation, reactive oxygen species, and microRNAs. Frontiers in Oncology 2022; 12: 980694.

Eick SM, Barrett ES, Van’t Erve TJ, et al. Association between prenatal psychological stress and oxidative stress during pregnancy. Paediatric and Perinatal Epidemiology 2018; 32(4): 318-326.

Kruk J, Aboul-Enein BH, Bernstein J, et al. Psychological stress and cellular aging in cancer: A meta-analysis. Oxidative Medicine and Cellular Longevity 2019, 2019: 1270397.

Xie WL, Wang XZ, Zhang GL. Clinical efficacy of Jiawei Xiaoyao Powder in the treatment of menopausal breast cancer patients with depression after chemotherapy and its influence on T lymphocyte subsets. Maternal and Child Health Care of China 2022; 37(09): 1562-1565.

Gentric G, Mieulet V, Mechta-Grigoriou F. Heterogeneity in cancer metabolism: New concepts in an old field. Antioxidants & Redox Signaling 2017; 26(9): 462-485.

Wu Q, Ishikawa T, Sirianni R, et al. 27-Hydroxycholesterol promotes cell-autonomous, ER-positive breast cancer growth. Cell Reports 2013; 5(3): 637-645.

Zhang HW, Tian T, Xiao Y, et al. From the perspective of neuroendocrine to explore the modern theoretical connotation of “liver governing and dispersing and regulating emotions”. Global Traditional Chinese Medicine 2018; 11(6): 850-853.

Ni H. Antidepressant effect of liver regulation therapy in rats via mediating mTORC1 autophagy signaling pathway. Guangzhou University of Chinese Medicine: Guangzhou, China, 2019.

Heng YQ, Chen LW, Fu PP. Clinical study on Shugan Jianpi formula for treatment of tumor-related depression. Asia-Pacific Traditional Medicine 2017; 13(24): 90-91.

Fan DH, Sun NN, Wu ZZ, et al. Study on the molecular mechanism of regulation of hippocampal neural plasticity by Chaihu Shugan powder in stagnation of liver Qi of depression model. World Journal of Integrated Traditional and Western Medicine 2018; 13(9): 1190-1193,1206.

Cheng Q. Clinical study on Fuzheng Kangfu mixture for tumor-associated depression of liver constraint and qi stagnation type. Journal of New Chinese Medicine 2019; 51(1): 167-170.

Ye JJ, Li G, Jia JH. Clinical observation of supplemented Ganmaidazao decoction in the treatment of 40 cases of cancer-related depression. Smart Healthcare 2017; 4(9): 114-115.

Li G, Ye JJ, Jia JH. Effect of supplemented Ganmai Dazao decoction on immune function in patients with depression of malignant tumor. World Latest Medicine Information (Electric Version) 2017; 17(66): 162-163.

Li XJ, Xiao F, Xiao ML. Clinical research on Guipi decoction combined with venlafaxine in the treatment of malignant tumor-related moderate to severe depression. Guiding Journal of Traditional Chinese Medicine and Pharmacology 2020; 26(12): 65-68.

Xing J, Wang JL, Wang CY, et al. Clinical efficacy of Shugan Xiehuo Yangxue Anshen in the treatment of insomnia. Global Traditional Chinese Medicine 2013; 6(7): 500-504.

Lin ZQ. Clinical observation on the efficacy of Liujunzi decoction combined with Banxia Houpu decoction in postoperative depression of gastric carcinoma. Chinese Journal of Clinical Rational Drug Use 2018; 11(8): 59-60.

Dai J. Clinical efficacy of Liujunzi decoction combined with Banxia Houpu decoction in postoperative depression of gastric carcinoma. Guide of Chinese Medicine 2017; 15(7): 179-180.

Sun TS. The regulation and mechanism of Tiaoqi Anshen decoction on the behaviors of rats under stress. Beijing University of Chinese Medicine: Beijing, China, 2019.

Chen RY, Liu SX, Xu MN. The effects of Huatan Liqi oral liquid on anxiety and depression disorder and systemic inflammation in patients with syndrome of phlegm-qi blocking acute exacerbation of chronic obstructive pulmonary disease. Tianjin Journal of Traditional Chinese Medicine 2022; 39(3): 303-307.